Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
The global spread of bacterial resistance to drugs used in therapy requires new potent and safe antimicrobial agents. DNA gyrases represent important targets in drug discovery. Schiff bases, thiazole, and triazole derivatives are considered key scaffolds in medicinal chemistry. Fifteen thiazolyl-tri...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/1/222 |
id |
doaj-c1051cc5272c449d941870a3ac6599e1 |
---|---|
record_format |
Article |
spelling |
doaj-c1051cc5272c449d941870a3ac6599e12020-11-24T22:36:06ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-01-0119122210.3390/ijms19010222ijms19010222Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase InhibitorsCristina Nastasă0Dan C. Vodnar1Ioana Ionuţ2Anca Stana3Daniela Benedec4Radu Tamaian5Ovidiu Oniga6Brînduşa Tiperciuc7Department of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 3-5 Mănăştur Street, RO-400372 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Pharmacognosy, “Iuliu Haţieganu” University of Medicine and Pharmacy, 12 Ion Creangă Street, RO-400010 Cluj-Napoca, RomaniaNational Institute for Research and Development for Cryogenic and Isotopic Technologies, 4th Uzinei Street, RO-240050 Râmnicu Vâlcea, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaThe global spread of bacterial resistance to drugs used in therapy requires new potent and safe antimicrobial agents. DNA gyrases represent important targets in drug discovery. Schiff bases, thiazole, and triazole derivatives are considered key scaffolds in medicinal chemistry. Fifteen thiazolyl-triazole Schiff bases were evaluated for their antibacterial activity, measuring the growth inhibition zone diameter, the minimum inhibitory concentration (MIC), and the minimum bactericidal concentration (MBC), against Gram-positive (Staphylococcus aureus, Listeria monocytogenes) and Gram-negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa) bacteria. The inhibition of S. aureus and S. typhimurium was modest. Compounds B1, B2, and B9 showed a similar effect as ciprofloxacin, the antimicrobial reference, against L. monocytogenes. B10 displayed a better effect. Derivatives B1, B5–7, B9, and B11–15 expressed MIC values lower than the reference, against L. monocytogenes. B5, B6, and B11–15 strongly inhibited the growth of P. aeruginosa. All compounds were subjected to an in silico screening of the ADMET (absorption, distribution, metabolism, elimination, toxicity) properties. Molecular docking was performed on the gyrA and gyrB from L. monocytogenes. The virtual screening concluded that thiazolyl-triazole Schiff base B8 is the best drug-like candidate, satisfying requirements for both safety and efficacy, being more potent against the bacterial gyrA than ciprofloxacin.http://www.mdpi.com/1422-0067/19/1/222Schiff basethiazoletriazoleantibacterial activityADMETmolecular dockingDNA-gyrase |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cristina Nastasă Dan C. Vodnar Ioana Ionuţ Anca Stana Daniela Benedec Radu Tamaian Ovidiu Oniga Brînduşa Tiperciuc |
spellingShingle |
Cristina Nastasă Dan C. Vodnar Ioana Ionuţ Anca Stana Daniela Benedec Radu Tamaian Ovidiu Oniga Brînduşa Tiperciuc Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors International Journal of Molecular Sciences Schiff base thiazole triazole antibacterial activity ADMET molecular docking DNA-gyrase |
author_facet |
Cristina Nastasă Dan C. Vodnar Ioana Ionuţ Anca Stana Daniela Benedec Radu Tamaian Ovidiu Oniga Brînduşa Tiperciuc |
author_sort |
Cristina Nastasă |
title |
Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors |
title_short |
Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors |
title_full |
Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors |
title_fullStr |
Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors |
title_full_unstemmed |
Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors |
title_sort |
antibacterial evaluation and virtual screening of new thiazolyl-triazole schiff bases as potential dna-gyrase inhibitors |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2018-01-01 |
description |
The global spread of bacterial resistance to drugs used in therapy requires new potent and safe antimicrobial agents. DNA gyrases represent important targets in drug discovery. Schiff bases, thiazole, and triazole derivatives are considered key scaffolds in medicinal chemistry. Fifteen thiazolyl-triazole Schiff bases were evaluated for their antibacterial activity, measuring the growth inhibition zone diameter, the minimum inhibitory concentration (MIC), and the minimum bactericidal concentration (MBC), against Gram-positive (Staphylococcus aureus, Listeria monocytogenes) and Gram-negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa) bacteria. The inhibition of S. aureus and S. typhimurium was modest. Compounds B1, B2, and B9 showed a similar effect as ciprofloxacin, the antimicrobial reference, against L. monocytogenes. B10 displayed a better effect. Derivatives B1, B5–7, B9, and B11–15 expressed MIC values lower than the reference, against L. monocytogenes. B5, B6, and B11–15 strongly inhibited the growth of P. aeruginosa. All compounds were subjected to an in silico screening of the ADMET (absorption, distribution, metabolism, elimination, toxicity) properties. Molecular docking was performed on the gyrA and gyrB from L. monocytogenes. The virtual screening concluded that thiazolyl-triazole Schiff base B8 is the best drug-like candidate, satisfying requirements for both safety and efficacy, being more potent against the bacterial gyrA than ciprofloxacin. |
topic |
Schiff base thiazole triazole antibacterial activity ADMET molecular docking DNA-gyrase |
url |
http://www.mdpi.com/1422-0067/19/1/222 |
work_keys_str_mv |
AT cristinanastasa antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors AT dancvodnar antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors AT ioanaionut antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors AT ancastana antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors AT danielabenedec antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors AT radutamaian antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors AT ovidiuoniga antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors AT brindusatiperciuc antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors |
_version_ |
1725721313540046848 |